Top Markets
Coin of the day
Harrow Health, Inc. 8.625% Senior Notes due 2026 Harrow Health, Inc. 8.625% Senior Notes due 2026

Harrow Health, Inc. 8.625% Senior Notes due 2026

HROWL
株式のランク #8091
Harrow, Inc. is a pharmaceutical company that specializes in the development,... Harrow, Inc. is a pharmaceutical company that specializes in the development, production, and distribution of innovative medications. Its business activities are primarily divided into two segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding division notably encompasses the operations of the ImprimisRx business. Co-founded by Mark L. Baum and Robert J. Kammer in January 2006, the firm maintains its corporate headquarters in Nashville, Tennessee.
株価
$25.61
最終同期: 2025-10-10
時価総額
$1.37B
変化(1日)
0.20%
変化(1年)
1.55%
US
取引 Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL)

カテゴリー

Harrow Health, Inc. 8.625% Senior Notes due 2026(HROWL)の利益
2026 時点の利益 TTM: 0
Harrow Health, Inc. 8.625% Senior Notes due 2026 の最新の財務報告によると、同社の現在の利益は 0 です。2026 年には 0 の利益を上げ、これは 2026 年の利益 0 と 同等 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
Harrow Health, Inc. 8.625% Senior Notes due 2026 の利益の推移(2026 〜 2026)
各年末の利益
利益 変化
提供された日付のデータは十分ではありません。